IBO logo

Impact BioMedical (IBO) Cash From Financing

IBO Annual CFF

$2.87 M
+$318.00 K+12.49%

01 December 2023

IBO Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IBO Quarterly CFF

$3.95 M
+$3.29 M+493.98%

01 September 2024

IBO Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IBO TTM CFF

$5.56 M
+$3.08 M+124.19%

01 September 2024

IBO TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IBO Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.5%+454.0%+117.1%
3 y3 years-+36.1%-43.1%
5 y5 years+258.1%+36.1%-43.1%

IBO Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+12.5%at high+154.6%at high+206.5%
5 y5-yearat high+258.1%at high+154.6%-43.1%+206.5%
alltimeall timeat high+258.1%at high+154.6%-43.1%+206.5%

Impact BioMedical Cash From Financing History

DateAnnualQuarterlyTTM
Sept 2024
-
$3.95 M(+494.0%)
$5.56 M(+124.2%)
June 2024
-
$665.00 K(-6.7%)
$2.48 M(-3.2%)
Mar 2024
-
$713.00 K(+207.3%)
$2.56 M(-10.6%)
Dec 2023
$2.87 M(+12.5%)
$232.00 K(-73.3%)
$2.87 M(-9.7%)
Sept 2023
-
$870.00 K(+16.6%)
$3.17 M(+3.2%)
June 2023
-
$746.00 K(-26.6%)
$3.08 M(+4.6%)
Mar 2023
-
$1.02 M(+88.7%)
$2.94 M(+15.4%)
Dec 2022
$2.55 M
$539.00 K(-30.3%)
$2.55 M(-148.8%)
DateAnnualQuarterlyTTM
Sept 2022
-
$773.00 K(+26.7%)
-$5.22 M(+68.8%)
June 2022
-
$610.00 K(-2.4%)
-$3.09 M(+438.8%)
Mar 2022
-
$625.00 K(-108.6%)
-$574.00 K(-122.5%)
Dec 2021
$2.55 M(+218.4%)
-$7.23 M(-349.1%)
$2.55 M(-73.9%)
Sept 2021
-
$2.90 M(-7.2%)
$9.78 M(+42.2%)
June 2021
-
$3.13 M(-16.5%)
$6.87 M(+83.5%)
Mar 2021
-
$3.75 M
$3.75 M
Dec 2019
$800.00 K
-
-

FAQ

  • What is Impact BioMedical annual cash flow from financing activities?
  • What is the all time high annual CFF for Impact BioMedical?
  • What is Impact BioMedical annual CFF year-on-year change?
  • What is Impact BioMedical quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Impact BioMedical?
  • What is Impact BioMedical quarterly CFF year-on-year change?
  • What is Impact BioMedical TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Impact BioMedical?
  • What is Impact BioMedical TTM CFF year-on-year change?

What is Impact BioMedical annual cash flow from financing activities?

The current annual CFF of IBO is $2.87 M

What is the all time high annual CFF for Impact BioMedical?

Impact BioMedical all-time high annual cash flow from financing activities is $2.87 M

What is Impact BioMedical annual CFF year-on-year change?

Over the past year, IBO annual cash flow from financing activities has changed by +$318.00 K (+12.49%)

What is Impact BioMedical quarterly cash flow from financing activities?

The current quarterly CFF of IBO is $3.95 M

What is the all time high quarterly CFF for Impact BioMedical?

Impact BioMedical all-time high quarterly cash flow from financing activities is $3.95 M

What is Impact BioMedical quarterly CFF year-on-year change?

Over the past year, IBO quarterly cash flow from financing activities has changed by +$3.24 M (+454.00%)

What is Impact BioMedical TTM cash flow from financing activities?

The current TTM CFF of IBO is $5.56 M

What is the all time high TTM CFF for Impact BioMedical?

Impact BioMedical all-time high TTM cash flow from financing activities is $9.78 M

What is Impact BioMedical TTM CFF year-on-year change?

Over the past year, IBO TTM cash flow from financing activities has changed by +$3.00 M (+117.10%)